Cell & Gene
Qihan Biotech Initiates Phase I IIa Dosing Of Allogeneic CAR T Therapy For Refractory Lupus
Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-...
December 22, 2025 | News
Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India
Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...
December 08, 2025 | News
Ajinomoto CELLiST Korea Launches New CELLiST AAV Production Supplement 1 to Boost Viral Vector Productivity
Ajinomoto Co in Tokyo collaborated with its United States based consolidated subsidiary Forge Biologics, a leading CDMO in adeno associated virus developme...
December 04, 2025 | News
Imugene and JW Therapeutics Launch First-in-Class “Mark and Kill” Solid Tumor Collaboration
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytic...
December 01, 2025 | News
Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma
Juventas Cell Therapy Co., Ltd. (hereinafter referred to as "Juventas") announced that its independently developed CAR-T cell therapy product, Inatica...
December 01, 2025 | News
IASO Bio Achieves Landmark Hong Kong Approval for Fucaso CAR-T Therapy
IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company dedicated to the discovery, development, manufacturing, and commerciali...
November 28, 2025 | Regulatory
eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing
eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, throug...
November 27, 2025 | News
Global Leaders Signal a Confident New Chapter for Cell and Gene Therapy at GenScript Global Forum London 2025
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...
November 24, 2025 | News
Thermo Fisher Opens Advanced Therapies Collaboration Center In Philadelphia To Accelerate Cell And Gene Therapy Development
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies ...
November 19, 2025 | News
Terumo BCT Achieves Breakthrough in Automated T Cell Therapy Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, announced an advancement in T cell therapy manufact...
November 19, 2025 | News
Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA
Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...
November 18, 2025 | News
Leucid Bio Reports Proof-of-Concept for LEU011 CAR-T Therapy in Solid Tumours from Ongoing AERIAL Trial
Proof-of-concept established for LEU011 in the treatment of relapsed/refractory solid tumours LEU011 has been well tolerated, with disease control obser...
November 11, 2025 | News
CorrectSequence Therapeutics Achieves World’s First Gene-Editing Success in Hyperlipidaemia Treatment
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy On&n...
November 07, 2025 | News
Nona Biosciences Expands Partnership with Umoja Biopharma to Advance Next-Generation In Vivo CAR-T Therapies
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), announced an evaluation and licen...
November 06, 2025 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
